Liv Hospital Ulus
Stem cell therapy for heart disease in Turkey typically costs from AUD $22,854 to AUD $34,282. Final pricing depends on the cell source, total cell count, and delivery method. In Australia, this treatment costs AUD $38,567 on average. Patients can save approximately 26% by travelling to centres in Istanbul or Antalya. Packages often include specialist consultations, cardiac imaging, and airport transfers.
Bookimed Expert Insight: High-volume centres like Liv Hospital Ulus provide value by combining JCI-accredited safety with international patient services. This ensures a smooth experience for Australians navigating complex regenerative treatments. Specialist doctors like Dr. Hakan Ucar and Dr. Dogan Erdogan bring expertise from institutions like the Mayo Clinic. Choosing a clinic with these credentials often provides better long-term value than selecting based on price alone.
| Turkey | Thailand | South Korea | |
| Stem cell therapy for heart disease | from AUD $22,854 | from AUD $28,568 | from AUD $42,228 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell therapy for heart disease upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell therapy for heart disease and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell therapy for heart disease journey.
Professor Fatih Koç brings elite international expertise to cardiac care, having trained at the world-renowned Cleveland Clinic in the United States.
Professor Dogan Erdogan is a highly academic cardiologist who completed a prestigious fellowship at the Mayo Clinic Echocardiography Lab in the United States.
Dr. Hakan Ucar is an interventional cardiologist at VM Medical Park Florya Hospital. He is board-certified by the European Society of Cardiology. Dr. Ucar specializes in complex coronary and peripheral interventions. He has published over 30 articles in international peer-reviewed journals. His research focuses on oxidative stress and coronary artery disease complexity.
Dr. Ertugrul Okuyan is an interventional cardiologist at Medipol Acibadem District Hospital in Istanbul. He specializes in treating structural heart disease and complex valve disorders. Dr. Okuyan serves as the Vice President of the Turkish Society of Cardiology. He is also a member of the European Society of Cardiology.
Stem cell therapy for heart disease in Turkey is an effective additional treatment. It focuses on regenerating tissue and improving heart function. Success rates reach 87% for patients with ischemia. Procedures are most effective in JCI-accredited facilities within 6 months of a cardiac event.
Bookimed Expert Insight: Turkish cardiac care stands out because specialists often hold elite US credentials. Dr. Dogan Erdogan and Dr. Fatih Koç both have experience from the Mayo Clinic and Cleveland Clinic. This international training helps patients receive Western-standard protocols at Turkish prices. These typically range from $16,000 to $24,000.
Patient Consensus: Patients in Turkey suggest treating this as an experimental boost rather than a total cure. They recommend confirming the delivery method. Patients should also ask their Australian GP for a clear follow-up plan for when they return home.
Ideal candidates for stem cell therapy for heart disease in Turkey include patients with chronic ischemic heart disease. This also applies to heart failure patients with limited success from standard treatments. Suitability depends on being stable for travel. Patients must provide recent echocardiogram results or angiography findings to specialist cardiologists.
Bookimed Expert Insight: Turkish centres like Liv Hospital Ulus merge JCI-accredited safety standards with specialist expertise. Many cardiology leads, including Dr. Dogan Erdogan and Dr. Fatih Koç, bring insights from the Mayo and Cleveland Clinics. This international training helps therapeutic protocols align with global standards for managing complex heart failure cases.
Patient Consensus: Patients suggest using this therapy as a supplementary option when standard medications or stents are insufficient. In Turkey, having detailed Cardiology reports ready helps the medical team perform a smoother assessment.
Heart disease treatment in Turkey primarily uses Mesenchymal Stem Cells (MSCs) and Endothelial Progenitor Cells (EPCs). These cells help repair damaged cardiac tissue. These adult stem cells target congestive heart failure and ischaemic conditions. They regenerate scarred muscle and improve blood supply through new vessel growth.
Bookimed Expert Insight: Turkish cardiac centres often combine stem cell therapy with interventional procedures. Specialists like Dr. Fatih Koç and Dr. Dogan Erdogan at Medical Park Antalya have international experience. They have trained at the Cleveland Clinic and Mayo Clinic. This helps stem cell protocols align with global standards in heart disease management.
Patient Consensus: Patients in Turkey find clinics provide broad stem cell options. They suggest requesting the exact cell type in writing. Many report clear communication about which cell types are used before starting treatment.
Stem cell therapy for heart disease in Turkish hospitals repairs damaged cardiac tissue. Specialists inject mesenchymal stem cells into the heart to improve function after heart attacks. These cells promote new blood vessel formation and help the cardiovascular system within JCI-accredited facilities.
Bookimed Expert Insight: Turkish cardiology centres often combine stem cell therapy with diagnostics like CT angiography. Research-led hospitals, such as Medical Park Antalya, employ specialists with Mayo Clinic training. This maintains global standards for tracking heart tissue recovery after the procedure.
Patient Consensus: Patients recommend confirming the specific cell source and delivery method before travelling. They find value in requesting written follow-up plans and telehealth options to monitor their recovery from Australia.
Recovery is rapid because specialists use minimally invasive techniques such as intracoronary infusion. Most patients move around within hours and leave hospital after 1–3 days. Initial healing takes 5–10 days in Turkey. Heart tissue regeneration shows results within 3–6 months.
Bookimed Expert Insight: While the procedure is fast, Turkish centres focus on long-term outcomes through precise diagnostics. Specialists like Dr Dogan Erdogan and Dr Fatih Koc bring high standards to monitor heart health. Both doctors trained at major US institutions including Mayo Clinic and Cleveland Clinic.
Turkey is a leading hub for cardiac stem cell therapy. It offers regenerative medicine infrastructure and JCI-accredited facilities. Specialists often use mesenchymal stem cells to repair heart tissue after attacks. Fast access to treatment through high-volume cardiac centres makes it a popular choice.
Bookimed Expert Insight: Turkish cardiac centres manage high patient volumes. Liv Hospital Ulus serves over 330,000 patients annually. This scale allows hospitals to invest in in-house cell processing labs. These labs are rare in smaller clinics and improve the potency of injected cells.
Patient Consensus: Patients value all-inclusive packages that bundle medical care with hotels and VIP transfers. Many appreciate direct access to emerging treatments that are often harder to find in Australia.